Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32.9Revenue $M0Net Margin (%)0Z-Score-5.9
Enterprise Value $M8.3EPS $-0.7Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %0Quick Ratio15.4Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %-34.5Current Ratio15.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-44.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-53.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M23.5ROI % (ttm)-70.8Gross Margin Increase y-yN

Gurus Latest Trades with BIOD

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIODDavid Swensen 2010-12-31 Sold Out $6.44 - $19.08
($10.24)
$ 1.34-87%Sold Out0
BIODDavid Swensen 2009-12-31 Buy 11.73%$14.16 - $21.04
($16.88)
$ 1.34-92%New holding, 903400 sh.903,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIOD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BIOD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIEBERMAN IRADirector 2013-12-20Buy10,800$2.29-41.48view
Pereira Brian JGDirector 2013-12-20Sell4,734$2.26-40.71view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-12-07Sell12,256$2.8-52.14view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-11-02Sell3,500$2.81-52.31view
Krasner Alan SethChief Medical Officer 2012-11-02Sell3,500$2.81-52.31view
DESOUZA ERROL BCEO 2012-09-20Buy10,000$3.34-59.88view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-03-13Sell2,096$2.36-43.22view
Pereira Brian JGDirector 2011-12-16Sell3,750$2.6-48.46view
Steiner SolomonDirector 2011-09-26Sell32,695$4.36-69.27view
Steiner SolomonDirector 2011-09-21Sell79,129$4.72-71.61view

Press Releases about BIOD :

    Quarterly/Annual Reports about BIOD:

    News about BIOD:

    Articles On GuruFocus.com
    cooldecency99 note on BIOD May 01 2010 
    Biodel Reports Third Quarter Fiscal Year 2009 Financial Results Aug 07 2009 
    Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009 Aug 03 2009 
    Biodel Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update Feb 05 2009 
    Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study Jan 30 2009 
    Biodel Inc. Reports Fourth Quarter and Fiscal Year 2008 Financial Results Dec 10 2008 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Mar 02 2015
    Biodel Reports First Quarter Fiscal Year 2015 Financial Results Mar 01 2015
    BIODEL INC Financials Feb 19 2015
    10-Q for Biodel, Inc. Feb 14 2015
    BIODEL INC Files SEC form 10-Q, Quarterly Report Feb 12 2015
    Pacira Resolves Promotion Issues Related to Exparel - Analyst Blog Feb 12 2015
    Biodel Reports First Quarter Fiscal Year 2015 Financial Results Feb 12 2015
    Q1 2015 Biodel Inc Earnings Release - 4:00 pm ET Feb 12 2015
    UCB's Neupro Positive in Parkinson's Disease Study in China - Analyst Blog Feb 09 2015
    McKesson Beats on Earnings & Revenues in Q3, Ups View - Analyst Blog Feb 06 2015
    On MannKind, Diabetics Have One Up On Wall Street Feb 06 2015
    Roche Reports Positive Data on Leukemia Drug Gazyva - Analyst Blog Feb 05 2015
    BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog Feb 05 2015
    Biodel to Report First Quarter Fiscal Year 2015 Financial Results on February 12, 2015 Feb 05 2015
    Merck KGaA, Precision Biologics to Develop Cancer Antibody - Analyst Blog Feb 04 2015
    Novartis' Alcon Receives FDA Approval for Pazeo Solution - Analyst Blog Feb 04 2015
    Salix Pharmaceuticals (SLXP) in Focus: Stock Jumps 5.1% - Tale of the Tape Feb 04 2015
    Will McKesson (MCK) Disappoint Q3 Earnings Estimates? - Analyst Blog Feb 03 2015
    Mallinckrodt Beats on Q1 Earnings, Sales Miss Estimates - Analyst Blog Feb 03 2015
    Will Mallinckrodt (MNK) Disappoint Q1 Earnings Estimates? - Analyst Blog Feb 02 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK